These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23248398)

  • 1. A study to evaluate the price control of antifungal medicines and its practical applicability.
    Sil A; Das NK; Ghosh P; Datta PK; Islam CN; Tripathi SK
    Indian J Pharmacol; 2012; 44(6):704-9. PubMed ID: 23248398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A questionnaire study on the management of onychomycosis: a Canadian perspective.
    Gupta AK; Shear NH
    Int J Dermatol; 1998 Jun; 37(6):457-60. PubMed ID: 9646138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial mycoses in Belgium: Burden, costs and antifungal drugs consumption.
    Becker P; Lecerf P; Claereboudt J; Devleesschauwer B; Packeu A; Hendrickx M
    Mycoses; 2020 May; 63(5):500-508. PubMed ID: 32048335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
    Angello JT; Voytovich RM; Jan SA
    Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
    Gupta AK
    Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global access to antifungal therapy and its variable cost.
    Kneale M; Bartholomew JS; Davies E; Denning DW
    J Antimicrob Chemother; 2016 Dec; 71(12):3599-3606. PubMed ID: 27516477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New antifungal agents in the treatment of superficial dermatomycoses].
    Degreef H
    Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
    Vanden Bossche H; Engelen M; Rochette F
    J Vet Pharmacol Ther; 2003 Feb; 26(1):5-29. PubMed ID: 12603774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antifungal medication for toenail onychomycosis.
    Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991-2009.
    Desai VC; Cavanaugh TM; Kelton CM; Guo JJ; Heaton PC
    Clin Ther; 2012 Oct; 34(10):2118-2131.e1. PubMed ID: 23031625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
    Zhao YJ; Khoo AL; Tan G; Teng M; Tee C; Tan BH; Ong B; Lim BP; Chai LY
    Antimicrob Agents Chemother; 2016 Jan; 60(1):376-86. PubMed ID: 26525782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic antifungal therapy: new options, new challenges.
    Wong-Beringer A; Kriengkauykiat J
    Pharmacotherapy; 2003 Nov; 23(11):1441-62. PubMed ID: 14620391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information system technologies' role in augmenting dermatologists' knowledge of prescription medication costs.
    DeMarco SS; Paul R; Kilpatrick RJ
    Int J Med Inform; 2015 Dec; 84(12):1076-84. PubMed ID: 26228652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antifungal agents.
    Lesher JL
    Dermatol Clin; 1992 Oct; 10(4):799-805. PubMed ID: 1327600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts in systemic and topical therapy for superficial mycoses.
    Millikan LE
    Clin Dermatol; 2010 Mar; 28(2):212-6. PubMed ID: 20347665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.